APA (7th ed.) Citation

Bernhardt, M., Gebhardt, C., & Utikal, J. (2014). Efficacy of vemurafenib in a trametinib-resistant stage IV melanoma patient: Letter. Clinical cancer research, 20(9), . https://doi.org/10.1158/1078-0432.CCR-13-2349

Chicago Style (17th ed.) Citation

Bernhardt, Mathias, Christoffer Gebhardt, and Jochen Utikal. "Efficacy of Vemurafenib in a Trametinib-resistant Stage IV Melanoma Patient: Letter." Clinical Cancer Research 20, no. 9 (2014). https://doi.org/10.1158/1078-0432.CCR-13-2349.

MLA (9th ed.) Citation

Bernhardt, Mathias, et al. "Efficacy of Vemurafenib in a Trametinib-resistant Stage IV Melanoma Patient: Letter." Clinical Cancer Research, vol. 20, no. 9, 2014, https://doi.org/10.1158/1078-0432.CCR-13-2349.